(GT)n Dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course

Clinical and Experimental Immunology

Volumn 153, Issue 1, 2008, Pages 81-85

  Hausmann, M ^a,b   Paul, G ^a,b,c   Kellermeier, S ^a,b   Frey, I ^a,b   Scholmerich J ^a   Falk, W ^a   Menzel, K ^a   Fried, M ^a,b   Herfarth, H ^a,d   Rogler, G ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UCSD MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Dinucleotide repeat polymorphism; Haem oxygenase 1; IBD; Promoter

Indexed keywords

EDETIC ACID; HEME OXYGENASE 1;

ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; DINUCLEOTIDE REPEAT; DISEASE COURSE; DNA FLANKING REGION; ENTERITIS; GENE AMPLIFICATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; ULCERATIVE COLITIS; UPREGULATION;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DINUCLEOTIDE REPEATS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROSATELLITE INSTABILITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK;

EID: 44949219404     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03674.x     Document Type: Article

References (22)

1. Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992 103 : 186 96.
2. Choi AM, Otterbein LE. Emerging role of carbon monoxide in physiologic and pathophysiologic states. Antioxid Redox Signal 2002 4 : 227 8.
3. Oberle S, Schwartz P, Abate A, Schroder H. The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells. Biochem Biophys Res Comms 1999 261 : 28 34.
4. Yesilkaya A, Altinayak R, Korgun DK. The antioxidant effect of free bilirubin on cumene-hydroperoxide treated human leukocytes. Gen Pharmacol 2000 35 : 17 20.
5. Paul G, Bataille F, Obermeier F et al. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol 2005 140 : 547 55.
6. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997 94 : 10925 30.
7. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997 94 : 10919 24.
8. Wang WP, Koo X, Guo MW et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol 2001 281 : G586 94.
9. Pileggi A, Molano RD, Berney T et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001 50 : 1983 91.
10. Pileggi A, Cattan P, Berney T et al. HO-1 upregulation protects the pancreatic cell line betaTC3 from cytokines and Fas-induced apoptosis. Transplant Proc 2001 33 : 266 7.
11. Exner M, Schillinger M, Minar E et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001 8 : 433 40.
12. Schillinger M, Exner M, Mlekusch W et al. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts. J Endovasc Ther 2003 10 : 557 65.
13. Geuken E, Buis CI, Visser DS et al. Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant 2005 5 : 1875 85.
14. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease. Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005 19 (Suppl. A 5 36.
15. Chen YH, Lin SJ, Lin MW et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002 111 : 1 8.
16. Schillinger M, Exner M, Minar E et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 2004 43 : 950 7.
17. Lavrovsky Y, Schwartzman ML, Abraham NG. Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochem Biophys Res Comms 1993 196 : 336 41.
18. Rogler G, Brand K, Vogl D et al. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998 115 : 357 69.
19. Chang KW, Lee TC, Yeh WI et al. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 2004 91 : 1551 5.
20. Kikuchi A, Yamaya M, Suzuki S et al. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 2005 116 : 354 60.
21. Yasuda H, Okinaga S, Yamaya M et al. Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism. J Med Genet 2006 43 : e17.
22. Yamada N, Yamaya M, Okinaga S et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000 66 : 187 95.